235 related articles for article (PubMed ID: 12199616)
1. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.
Pass RF; Burke RL
Semin Pediatr Infect Dis; 2002 Jul; 13(3):196-204. PubMed ID: 12199616
[TBL] [Abstract][Full Text] [Related]
2. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.
Wang D; Fu TM
Curr Opin Virol; 2014 Jun; 6():13-23. PubMed ID: 24632198
[TBL] [Abstract][Full Text] [Related]
3. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R;
Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
[TBL] [Abstract][Full Text] [Related]
5. Immunization to prevent congenital cytomegalovirus infection.
Adler SP
Br Med Bull; 2013; 107():57-68. PubMed ID: 23954939
[TBL] [Abstract][Full Text] [Related]
6. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Development for Cytomegalovirus.
Inoue N; Abe M; Kobayashi R; Yamada S
Adv Exp Med Biol; 2018; 1045():271-296. PubMed ID: 29896672
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus vaccines: at last, a major step forward.
Schleiss MR
Herpes; 2009 Jan; 15(3):44-5. PubMed ID: 19306601
[TBL] [Abstract][Full Text] [Related]
9. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
10. Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
Lanzieri TM; Gastañaduy PA; Gambhir M; Plotkin SA
J Infect Dis; 2020 Mar; 221(Suppl 1):S86-S93. PubMed ID: 32134475
[TBL] [Abstract][Full Text] [Related]
11. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
12. The March towards a Vaccine for Congenital CMV: Rationale and Models.
Bialas KM; Permar SR
PLoS Pathog; 2016 Feb; 12(2):e1005355. PubMed ID: 26866914
[No Abstract] [Full Text] [Related]
13. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.
Dasari V; Smith C; Khanna R
Expert Rev Vaccines; 2013 Jun; 12(6):661-76. PubMed ID: 23750795
[TBL] [Abstract][Full Text] [Related]
14. Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.
Schleiss MR; Permar SR; Plotkin SA
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046308
[TBL] [Abstract][Full Text] [Related]
15. The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.
McCormick AL; Mocarski ES
Cell Mol Immunol; 2015 Mar; 12(2):170-9. PubMed ID: 25544503
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus vaccines and methods of production (WO20009049138): the emerging recognition of the importance of virus neutralization at the epithelial/endothelial interface.
Schleiss MR
Expert Opin Ther Pat; 2010 Apr; 20(4):597-602. PubMed ID: 20302454
[TBL] [Abstract][Full Text] [Related]
17. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
18. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
Plachter B
Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
[TBL] [Abstract][Full Text] [Related]
19. Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
Krause PR; Roberts J
J Infect Dis; 2020 Mar; 221(Suppl 1):S103-S108. PubMed ID: 32134485
[TBL] [Abstract][Full Text] [Related]
20. Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
Gonczol E; Plotkin S
Expert Opin Biol Ther; 2001 May; 1(3):401-12. PubMed ID: 11727514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
